Literature DB >> 9309690

Point mutations in the mitochondrial tRNA(Lys) gene: implications for pathogenesis and mechanism.

J P Masucci1, E A Schon, M P King.   

Abstract

MERRF (myoclonic epilepsy with ragged-red fibers) is a severe, multisystem disorder characterized by myoclonus, seizures, progressive cerebellar syndrome, muscle weakness, and the presence of ragged-red fibers in the muscle biopsy. MERRF is associated with heteroplasmic point mutations, either A8344G or T8356C, in the gene encoding the mitochondrial tRNA(Lys). The human rho degree cell system was utilized to examine the phenotypic consequences of these mutations, and to investigate their molecular genetic causes. Wild-type and mutant transmitochondrial cell lines harboring a pathogenic point mutation at either A8344G or T8356C in the human mitochondrial tRNA(Lys) gene were isolated and examined. Mitochondrial transformants containing 100% mutated mitochondrial DNAs (mtDNAs) exhibited severe defects in respiratory chain activity, in the rates of protein synthesis, and in the steady-state levels of mitochondrial translation products as compared with mitochondrial transformants containing 100% wild-type mtDNAs. In addition, both mutant cell lines exhibited the presence of aberrant mitochondrial translation products. These results demonstrate that two different mtDNA point mutations in tRNA(Lys) result in fundamentally identical defects at the cellular level, and that these specific protein synthesis abnormalities contribute to the pathogenesis of MERRF.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9309690

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  13 in total

1.  Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation.

Authors:  M P King; G Attardi
Journal:  Science       Date:  1989-10-27       Impact factor: 47.728

2.  Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation.

Authors:  J M Shoffner; M T Lott; A M Lezza; P Seibel; S W Ballinger; D C Wallace
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

3.  On the directional specificity of ribosome frameshifting at a "hungry" codon.

Authors:  D Lindsley; J Gallant
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

4.  MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNA(Lys) and premature translation termination.

Authors:  J A Enriquez; A Chomyn; G Attardi
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

5.  Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF).

Authors:  L Boulet; G Karpati; E A Shoubridge
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

Review 6.  Lysyl-tRNA synthetase.

Authors:  W Freist; D H Gauss
Journal:  Biol Chem Hoppe Seyler       Date:  1995-08

7.  Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes.

Authors:  M P King; Y Koga; M Davidson; E A Schon
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

8.  Analysis of cybrids harboring MELAS mutations in the mitochondrial tRNA(Leu(UUR)) gene.

Authors:  Y Koga; M Davidson; E A Schon; M P King
Journal:  Muscle Nerve Suppl       Date:  1995

9.  In vitro analysis of mutations causing myoclonus epilepsy with ragged-red fibers in the mitochondrial tRNA(Lys)gene: two genotypes produce similar phenotypes.

Authors:  J P Masucci; M Davidson; Y Koga; E A Schon; M P King
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

10.  Complementation of mutant and wild-type human mitochondrial DNAs coexisting since the mutation event and lack of complementation of DNAs introduced separately into a cell within distinct organelles.

Authors:  M Yoneda; T Miyatake; G Attardi
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

View more
  5 in total

1.  MitoTALEN: A General Approach to Reduce Mutant mtDNA Loads and Restore Oxidative Phosphorylation Function in Mitochondrial Diseases.

Authors:  Masami Hashimoto; Sandra R Bacman; Susana Peralta; Marni J Falk; Anne Chomyn; David C Chan; Sion L Williams; Carlos T Moraes
Journal:  Mol Ther       Date:  2015-07-10       Impact factor: 11.454

Review 2.  Mitochondrial DNA mutation-elicited oxidative stress, oxidative damage, and altered gene expression in cultured cells of patients with MERRF syndrome.

Authors:  Shi-Bei Wu; Yi-Shing Ma; Yu-Ting Wu; Yin-Chiu Chen; Yau-Huei Wei
Journal:  Mol Neurobiol       Date:  2010-04-23       Impact factor: 5.590

3.  Decreased mitochondrial tRNALys steady-state levels and aminoacylation are associated with the pathogenic G8313A mitochondrial DNA mutation.

Authors:  Sandra R Bacman; David P Atencio; Carlos T Moraes
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

4.  Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease.

Authors:  Michael H Yan; Xinglong Wang; Xiongwei Zhu
Journal:  Free Radic Biol Med       Date:  2012-11-29       Impact factor: 7.376

Review 5.  Neuroimaging in mitochondrial disorders.

Authors:  Andrea L Gropman
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.